Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
225,970,109
-
Number of holders
-
842
-
Total 13F shares, excl. options
-
234,666,772
-
Shares change
-
-3,833,961
-
Total reported value, excl. options
-
$44,173,109,626
-
Value change
-
-$691,902,449
-
Put/Call ratio
-
1.23%
-
Number of buys
-
374
-
Number of sells
-
-368
-
Price
-
$188.13
Significant Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q2 2017
920 filings reported holding ELV - Elevance Health, Inc. - Common Stock as of Q2 2017.
Elevance Health, Inc. - Common Stock (ELV) has 842 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 234,666,772 shares
.
Largest 10 shareholders include BlackRock Inc. (22,675,167 shares), VANGUARD GROUP INC (17,804,726 shares), PRICE T ROWE ASSOCIATES INC /MD/ (13,546,421 shares), STATE STREET CORP (11,250,701 shares), FMR LLC (10,053,796 shares), BARROW HANLEY MEWHINNEY & STRAUSS LLC (6,645,303 shares), BAILLIE GIFFORD & CO (4,957,127 shares), WELLINGTON MANAGEMENT GROUP LLP (4,317,641 shares), Orbis Allan Gray Ltd (4,252,021 shares), and Invesco Ltd. (4,247,624 shares).
This table shows the top 842 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.